Debiopharm Group

Debiopharm Group is a biopharmaceutical development specialist based in Lausanne, Switzerland, focusing on in-licensing promising biologics and small molecule drug candidates for global registration. The group aims to maximize the commercial potential of its products through out-licensing agreements with pharmaceutical partners for sales and marketing. It operates multiple investment arms, including the Debiopharm Innovation Fund, which invests in early-stage companies within the biotechnology, diagnostics, and digital health sectors, focusing on smart data and biomarker development. This fund typically invests between $1 million and $10 million, seeking minority stakes and board representation in its portfolio companies. Additionally, Debiopharm Investment engages in private equity and real estate investments, targeting mature companies in IT security and renewable sectors, as well as residential and commercial properties primarily in Western Europe. With a commitment to long-term investments and active involvement in corporate governance, Debiopharm Group drives its portfolio companies toward successful market exits.

Thierry Mauvernay

President and Delegate of the Board

Alexandra Le Coz Sanchez

Associate Director, Private Equity Department, Debiopharm Investment S.A

Past deals in Switzerland

Coorpacademy

Series B in 2016
Coorpacademy S.A. is a Swiss company based in Lausanne, established in 2013. It specializes in developing online training courses and innovative learning solutions, including MOOCs. The company offers a learning experience platform that features a diverse catalog of training courses, which are designed to provide short, accessible sessions that users can engage with at any time and on various devices. This platform aims to revolutionize digital learning for employees by delivering customized content tailored to individual needs. Coorpacademy was founded by Frederick Benichou, Jean-Marc Tassetto, and Arnauld Mitre.

Coorpacademy

Series A in 2014
Coorpacademy S.A. is a Swiss company based in Lausanne, established in 2013. It specializes in developing online training courses and innovative learning solutions, including MOOCs. The company offers a learning experience platform that features a diverse catalog of training courses, which are designed to provide short, accessible sessions that users can engage with at any time and on various devices. This platform aims to revolutionize digital learning for employees by delivering customized content tailored to individual needs. Coorpacademy was founded by Frederick Benichou, Jean-Marc Tassetto, and Arnauld Mitre.

BPA Solutions

Funding Round in 2013
BPA Solutions SA specializes in providing innovative business applications that enhance Microsoft SharePoint and Office 365. Founded in 2001 and headquartered in Yverdon-les-Bains, Switzerland, the company develops a range of solutions including BPA CRM for customer relationship management, BPA Quality for quality management, and BPA Risk for tracking business activities in complex environments. Additional offerings include BPA Project for project management, BPA Recruiting for candidate management, and Self-Service tools for process sharing. BPA Solutions also features a Solutions Suite to monitor critical business processes and mobile solutions, along with professional services such as training, consulting, and support. The company delivers its software on-premise, through private or Microsoft clouds, and in hybrid environments, serving clients globally.

Skioo

Venture Round in 2013
Skioo is a company dedicated to enhancing the skiing experience by providing a seamless platform for ski ticketing and adventure booking. The Skioo Pass offers skiers instant access to an extensive network of partner resorts in Switzerland and beyond. By integrating with the systems of ski resorts, ski-lift operators, and online accommodation platforms, Skioo simplifies the booking process for users, allowing them to purchase ski tickets from a single interface. Additionally, the Skioo App fosters a community of skiing enthusiasts and provides valuable information and features to enrich the skiing experience. Founded in 2019 as part of Skitude, Skioo is driven by a team of outdoor enthusiasts and collaborates with notable technology partners to deliver its services effectively.

Compliant Concept

Venture Round in 2013
Compliant Concept AG, based in Dübendorf, Switzerland, specializes in developing advanced bed systems aimed at the treatment and prevention of pressure ulcers. Founded in 2009 as a spinoff from the Empa and ETH Zurich, the company leverages technology to enhance patient care in hospitals and nursing homes. Its intelligent bed systems incorporate mobility monitors that assess clinical risks and identify factors influencing pressure ulcer development, such as medication and pre-bedtime activities. By automating routine tasks, Compliant Concept's solutions help reduce the workload of healthcare professionals, allowing them to focus on providing better care to patients while improving overall comfort and efficiency in healthcare settings.

Spinomix

Series A in 2013
Spinomix is a Swiss technology platform company based at the Ecole Polytechnique Fédérale de Lausanne (EPFL), specializing in innovative sample processing solutions for the life sciences sector. The company aims to establish a new standard for the processing of biochemical substances, enhancing the quality and efficiency of sample capture and extraction, which is crucial for accurate diagnostics in various human diseases. Spinomix's flagship products, MagPhase™ and FibroTrap™, significantly improve the analysis of complex samples such as blood, urine, and food matrices, which are often challenging to process. The company recognizes the labor-intensive nature of current sample processing methods and sees a substantial opportunity to streamline these processes. Spinomix targets key growth markets, including nucleic acids extraction, cell separation, food safety, and molecular diagnostics for infectious diseases. By focusing on product innovation and market validation, Spinomix is building collaboration agreements with industry leaders to validate its technologies and develop strategic commercial partnerships for licensing its products.

Biocartis

Series D in 2012
Biocartis SA, established in 2007 and headquartered in Lausanne, Switzerland, is a molecular diagnostics company specializing in developing diagnostic technology platforms for multiplexed detection of bio-analytes such as proteins, nucleic acids, and small molecules. The company focuses on integrated molecular and immunodiagnostics using its proprietary micro-technology platform, offering products like the Idylla system for oncology and infectious disease segments. These products aid in early detection, staging, treatment selection, and monitoring of diseases by analyzing bio-molecules associated with risk factors. Biocartis generates revenue primarily through product sales.

Skioo

Seed Round in 2012
Skioo is a company dedicated to enhancing the skiing experience by providing a seamless platform for ski ticketing and adventure booking. The Skioo Pass offers skiers instant access to an extensive network of partner resorts in Switzerland and beyond. By integrating with the systems of ski resorts, ski-lift operators, and online accommodation platforms, Skioo simplifies the booking process for users, allowing them to purchase ski tickets from a single interface. Additionally, the Skioo App fosters a community of skiing enthusiasts and provides valuable information and features to enrich the skiing experience. Founded in 2019 as part of Skitude, Skioo is driven by a team of outdoor enthusiasts and collaborates with notable technology partners to deliver its services effectively.

Biocartis

Series C in 2011
Biocartis SA, established in 2007 and headquartered in Lausanne, Switzerland, is a molecular diagnostics company specializing in developing diagnostic technology platforms for multiplexed detection of bio-analytes such as proteins, nucleic acids, and small molecules. The company focuses on integrated molecular and immunodiagnostics using its proprietary micro-technology platform, offering products like the Idylla system for oncology and infectious disease segments. These products aid in early detection, staging, treatment selection, and monitoring of diseases by analyzing bio-molecules associated with risk factors. Biocartis generates revenue primarily through product sales.

Biocartis

Series B in 2010
Biocartis SA, established in 2007 and headquartered in Lausanne, Switzerland, is a molecular diagnostics company specializing in developing diagnostic technology platforms for multiplexed detection of bio-analytes such as proteins, nucleic acids, and small molecules. The company focuses on integrated molecular and immunodiagnostics using its proprietary micro-technology platform, offering products like the Idylla system for oncology and infectious disease segments. These products aid in early detection, staging, treatment selection, and monitoring of diseases by analyzing bio-molecules associated with risk factors. Biocartis generates revenue primarily through product sales.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.